top of page

"Molecular Recognition-Based Antibody Analysis" - Presented by Dr. Meena Narsimhan

at Antibody Engineering and Therapeutics

Proteons in the Proteometer

THE CANARY IN
THE FERMENTOR

Novilytic Canary

Eliminate Sample Prep & Method Development

Arrow Down

SOLUTIONS

L Horizontal.jpg
Proteometer-L Kit

Identifies & quantifies titer + relative aggregate content in clarified fermentation broth, in 10 mins

For mAbs, multi-specifics, recombinant proteins containing an Fc domain

UFT 2.jpg

Proteometer-UFT Kit

Runs at-line titer measurements in under 90 seconds

For mAbs, multi-specifics, recombinant proteins containing an FC domain

ABOUT

Novilytic's Proteometer® product line streamlines drug development and clone selection by eliminating sample preparation steps. 

--


“Canary in the coal mine” refers to using birds to detect odorless but highly poisonous carbon monoxide gas to keep miners safe. Novilytic has applied this same premise to pharmaceutical laboratories.

Our nanotechnology acts as “The Canary in the Fermentor” by allowing scientists to monitor batch quality in-process. 

The Proteometer-L, aka “proteoform meter,” performs at-line, real-time batch analysis - for human or humanized mAbs, multipecifics, or proteins containing an Fc domain - roughly every 10 minutes and eliminates the need for sample preparation and method development.

TESTIMONIALS

Architectural Structure

"We use the Proteometer-L Kit for the rapid analysis of mAbs and bispecifics for titer and aggregate content from cell-free filtrate samples.

 

It eliminates sample preparation steps, Protein A purification, and mass spectrometry analysis steps.

 

I would recommend the Proteometer to any pharmaceutical company to quickly and accurately quantitate titer and aggregate content."

Harsha Gunawardena
Senior Principal Scientist
Johnson & Johnson

Architectural Structure

“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb (therapeutic mAbs) proteoforms during fermentation.

 

The approach improves product safety, reduces COPQ and post-release testing, and paves the way for real-time product release, reducing inventory costs.”

Martin Long, BSc.
President & CEO
Performance Validation, Inc.

(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)

Analytical testing in DD & clone selection is 5-10 days

Proteometer trims this to one day 

Savings = $800K - $1.8M per clone selection DoE

bottom of page